Rituximab

From Citizendium

Revision as of 17:07, 1 March 2009 by imported>Robert Badgett (New page: In medicine, rituximab is a medication that is "a genetically engineered anti-CD20 ([http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein&term=NP_690605 Entrez protein]) [[antib...)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

In medicine, rituximab is a medication that is "a genetically engineered anti-CD20 (Entrez protein) antibody for the treatment of B-cell lymphoma."^[1]

References

↑ Anonymous (2024), Rituximab (English). Medical Subject Headings. U.S. National Library of Medicine.

External links

The most up-to-date information about Rituximab and other drugs can be found at the following sites.

Rituximab - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
Rituximab - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
Rituximab - Detailed information from DrugBank.

Retrieved from "https://citizendium.org/wiki/index.php?title=Rituximab&oldid=589209"